Page 3 - Oncology Program News Today

/PRNewswire/ -- Rady Childrens Hospital-San Diego, one of the nations top pediatric health care systems, and the University of California San Diego are...

"Banner Health plans to construct a 119,500 sq ft medical office building in Scottsdale, AZ as part of a $400M hospital complex. Expected to open by 202

People who live in areas with social and environmental adversities may have up to twice the increased risk for developing heart disease and stroke, according to new research published today in the Journal of the American Heart Association, an open access, peer-reviewed journal of the American Heart Association.

– Industry veteran brings extensive clinical development experience to AVEO Oncology leadership team as Chief Medical Officer – – Formation of a Scientific Advisory Committee from...

People who live in areas with social and environmental adversities may have up to twice the increased risk for developing heart disease and stroke, according to new research published today in the Journal of the American Heart Association, an open access, peer-reviewed journal of the American Heart Association.

People living in neighborhoods with high rates of environmental and socioeconomic problems may face a higher risk for heart disease and...

Clear registration pathway and FDA agreement on the ORALTO Phase 3 trial for MAT2203 represent critical steps forward and supports partnership discussions Continued success of Compassionate/Expanded...

In case you missed it, below is a recap of all drugs that have been approved by the FDA in February 2024.

The Food and Drug Administration approve Amtagvi, a TIL therapy, for patients with advanced melanoma who had disease progression on or after a checkpoint inhibitor and targeted therapy.

Zev A. Wainberg, MD, discusses the FDA approval of NALIRIFOX for patients with metastatic pancreatic ductal adenocarcinoma.